Status:
COMPLETED
Retrospective Study to Capture Dosing and Treatment Outcome Data in Participants With Severe Congenital Protein C Deficiency Who Were Treated With Protein C Concentrate Under an Emergency Use IND
Lead Sponsor:
Baxalta now part of Shire
Conditions:
Protein C Deficiency
Eligibility:
All Genders
Brief Summary
This is a data collection study with the purpose of capturing dosing and treatment outcome data in participants with severe congenital protein C deficiency who were treated with protein C concentrate ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Participant treated with protein C concentrate under a Baxter Healthcare Corporation Emergency Use IND.
- Participant with diagnosis of severe congenital protein C deficiency.
- Participant or parent/legally authorized representative has provided written informed consent.
Exclusion
Key Trial Info
Start Date :
June 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT00161720
Start Date
June 1 2005
End Date
December 1 2005
Last Update
April 8 2021
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Children´s Hospital of Los Angeles
Los Angeles, California, United States, 90027
2
Children´s Hospital Denver
Denver, Colorado, United States, 80218
3
Evans Army Hospital
Fort Carson, Colorado, United States, 80973
4
Children´s Hospital Boston
Boston, Massachusetts, United States, 02115